Aztreonam
生产企业：Gilead sciences inc, Bristol myers squibb，另有 2 家
Aztreonam is a beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria.
Aztreonam is a beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria.
The bactericidal action of aztreonam results from the inhibition of bacterial cell wall synthesis due to a high affinity of aztreonam for penicillin binding protein 3 (PBP3). By binding to PBP3, aztreonam inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that aztreonam interferes with an autolysin inhibitor.
For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.
共 12 项相关疾病
